EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments

Sarfaraz K Niazi iD

Pharmaceuticals · 16.06.2025 · 18 (6) · 901

DOI: 10.3390/ph18060901 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 16.06.2025. Verfasst von Sarfaraz K Niazi. Beteiligte Einrichtung: College of Pharmacy, University of Illinois, Chicago, IL 60612, USA. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integrating artificial intelligence (AI) and machine learning (ML) into pharmaceutical manufacturing processes holds great promise for enhancing efficiency, product quality, and regulatory compliance. However, implementing good manufacturing practices (GMP) in regulated environments introduces complex challenges related to validation, data integrity, risk management, and regulatory oversight. This review article comprehensively analyzes current regulatory frameworks and guidance for AI/ML in pharmaceutical Good Manufacturing Practice (GMP) settings, identifies gaps and uncertainties, and proposes considerations for future policy development. Emphasis is placed on understanding regulatory expectations across various agencies, including the US FDA, EMA, and MHRA. This article examines verified case studies and pilot programs that demonstrate the successful application of AI/ML under regulatory scrutiny, as well as recent developments in regulatory frameworks and implementation strategies. Ultimately, this article emphasizes the importance of a risk-based life cycle approach and the need for advancements in regulatory science to accommodate the dynamic nature of AI/ML technologies.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligence (AI)digital transformationgood manufacturing practice (GMP)machine learning (ML)pharmaceutical regulationvalidation frameworks

Autor:innen und Institutionen

  • College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.

ORCID-Profile: Sarfaraz K Niazi

Zitieren

APA

Niazi, S. K. (2025). Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments. Pharmaceuticals, 18(6), 901. https://doi.org/10.3390/ph18060901

Vancouver

Niazi SK. Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments. Pharmaceuticals. 2025;18(6):901. doi:10.3390/ph18060901

BibTeX
@article{Niazi2025,
  author = {Niazi, Sarfaraz K},
  title = {Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {6},
  pages = {901},
  doi = {10.3390/ph18060901}
}
Kostenlos starten →